Cargando…
High-flow nasal cannula for COVID-19 patients: risk of bio-aerosol dispersion
High-flow nasal cannula does not generate higher risk of bio-aerosol dispersion than conventional oxygen masks https://bit.ly/2Yn0RQn
Autores principales: | Li, Jie, Fink, James B., Ehrmann, Stephan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453737/ https://www.ncbi.nlm.nih.gov/pubmed/32859677 http://dx.doi.org/10.1183/13993003.03136-2020 |
Ejemplares similares
-
High-flow nasal cannula for COVID-19 patients: low risk of bio-aerosol dispersion
por: Li, Jie, et al.
Publicado: (2020) -
High-flow nasal cannula for COVID-19 patients: risk of bio-aerosol dispersion
por: Elshof, Judith, et al.
Publicado: (2020) -
Placing a mask on COVID-19 patients during high-flow nasal cannula therapy reduces aerosol particle dispersion
por: Li, Jie, et al.
Publicado: (2021) -
High-flow nasal oxygen: a safe, efficient treatment for COVID-19 patients not in an ICU
por: Guy, Tiphaine, et al.
Publicado: (2020) -
COVID-19: minimising risk to healthcare workers during aerosol-producing respiratory therapy using an innovative constant flow canopy
por: Adir, Yochai, et al.
Publicado: (2020)